AMELLO JASON (Chief Financial Officer) received a stock award from CANDEL THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 11/28/2023ACC: 0001209191-23-056802
Officer· Chief Financial Officer
Since Sep 2022
+125.72K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
125.72K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+125.72K
Price / share
—
Trade value
—
% of position
130.4%
11/26/2023
96.44K→222.16K
Total
Net shares
+125.72K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/26/2023 | A · Award | +125.72K | — | — | 130.4% | 96.44K | 222.16K |
| Total | +125.72K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported